RECOVERY Collaborative Group 2023, ' Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. ', Lancet (London, England), vol. 401, no. 10387, pp. 1499-1507 . https://doi.org/10.1016/S0140-6736(23)00510-X
Jarman, R D, Colclough, A, Mcdermott, C, Botker, M, Knudsen, L, Harris, T, Albaroudi, B, Albaroudi, O, Haddad, M, Darke, R, Berry, E, Breslin, T, Fitzpatrick, G, Flanagan, L, Olusanya, O, Craver, D, Omar, A, Simpson, T, Cherian, N, Dore, M, Prosen, G, Kay, S, Villén-Villegas, T, Gargani, L, Carley, S, Woo, M, Dupriez, F, Hussain, A, Via, G, Connolly, J A, Peck, M, Melniker, L, Walden, A, Attard Biancardi, M A, Żmijewska-Kaczor, O, Lalande, E, Geukens, P, Mclaughlin, R, Olszynski, P, Hoffmann, B, Chin, E, Muhr, C, Kim, D J, Mercieca, A, Shukla, D, Hayward, S, Smith, M, Gaspari, R, Smallwood, N, Pes, P, Tavazzi, G, Corradi, F, Lambert, M, Morris, C, Trauer, M, Baker, K, Bystrzycki, A, Goudie, A, Liu, R, Rudd, L, Dietrich, C F, Jenssen, C & Sidhu, P S 2023, ' EFSUMB Clinical Practice Guidelines for Point-of-Care Ultrasound : Part One (Common Heart and Pulmonary Applications) SHORT VERSION ', Ultraschall in der Medizin, vol. 44, no. 1, pp. 36-49 . https://doi.org/10.1055/a-1882-6116
Mumford, A D & Gibbison, B J J 2022, ' Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial and updated meta-analysis ', Lancet, vol. 400, no. 10349, pp. 359-368 . https://doi.org/10.1016/S0140-6736(22)01109-6 Dimitriadis, G K 2022, ' Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial and updated meta-analysis ', Lancet, vol. 400, no. 10349, pp. 359-368 . https://doi.org/10.1016/S0140-6736(22)01109-6 RECOVERY Collaborative Group & Dark, P 2022, ' Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis ', Lancet . https://doi.org/10.1016/S0140-6736(22)01109-6
Lancet (London, England) LANCET RECOVERY Collaborative Group 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY) a randomised controlled, open-label, platform trial ', The Lancet, vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7 Mumford, A D 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised controlled, open-label, platform trial ', Lancet, vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7 Group, RECOVERY C & Dark, P 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. ', Lancet (London, England), vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7
RECOVERY Collaborative Group & Downey, D 2022, ' Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', The Lancet, vol. 399, no. 10325, pp. 665-676 . https://doi.org/10.1016/S0140-6736(22)00163-5 Mumford, A D 2022, ' Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 399, no. 10325, pp. 665-676 . https://doi.org/10.1016/S0140-6736(22)00163-5 Lancet (London, England) Group, RECOVERY C, Felton, T, Dark, P & Mathioudakis, A 2022, ' Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 399, no. 10325, pp. 665-676 . https://doi.org/10.1016/S0140-6736(22)00163-5